Literature DB >> 12510248

[Non-surgical therapy of iatrogenic false aneurysms].

G Görge1, T Kunz, M Kirstein.   

Abstract

SUMMARY: False aneurysms occur after 0.1 - 1.5 % of all diagnostic and up to 6 % of all therapeutic percutaneous interventions. Surgery used to be the treatment of choice in symptomatic patients. But two non-invasive measures of treatment gain more attention: ultrasound guided compression (UGC) and ultrasound guided thrombin injection (UGTI). UGC with compression times from 30 - 120 min is effective in 80 % of patients without anticoagulation. However, UGC is often painful and results in prolongation of in-hospital time. UGTI is effective in 95 % of patients. Usually, 100 - 2000 U of thrombin are injected into the false aneurysm. UGTI is also effective in the presence of anticoagulation or antiplatelet therapy. UGTI is not indicated in patients with a large communication with the native vessel and in arterio-venous-fistulas. In patients with large haematomas, ongoing bleeding, damage of the native vessel, compression of arteries, veins or neurological deficits, or with infections, early surgical repair is still the treatment of choice.

Entities:  

Mesh:

Year:  2003        PMID: 12510248     DOI: 10.1055/s-2003-36329

Source DB:  PubMed          Journal:  Dtsch Med Wochenschr        ISSN: 0012-0472            Impact factor:   0.628


  3 in total

Review 1.  "To-and-fro" waveform in the diagnosis of arterial pseudoaneurysms.

Authors:  Mustafa Z Mahmoud; Mohammed Al-Saadi; Abdulwahab Abuderman; Khalid S Alzimami; Mohammed Alkhorayef; Babikir Almagli; Abdelmoneim Sulieman
Journal:  World J Radiol       Date:  2015-05-28

2.  [Pseudoaneurysm - a rare complication after insertion of a distal locking bolt of an intramedullary femur nail].

Authors:  O Kilian; A C Langheinrich; J Tofighi; R Schnettler
Journal:  Unfallchirurg       Date:  2008-11       Impact factor: 1.000

3.  Endovascular treatment of iatrogenic axillary artery pseudoaneurysm under echographic control: a case report.

Authors:  Daniela Mazzaccaro; Giovanni Malacrida; Maria T Occhiuto; Silvia Stegher; Domenico G Tealdi; Giovanni Nano
Journal:  J Cardiothorac Surg       Date:  2011-05-27       Impact factor: 1.637

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.